Back to ABT
Candriam S.C.A. ABT Position History
Abbott Laboratories • Healthcare
Quarters held
6
Latest value
$114.2M
Q3 2026
Peak value
$157M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $157M |
| Q4 2025 | $127.7M |
| Q4 2025 | $127.7M |
| Q1 2026 | $64.1M |
| Q2 2026 | $19.1M |
| Q3 2026 | $114.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $114.2M | 1.15M | — | — |
| Q2 2026 | $19.1M | 211.2K | — | — |
| Q1 2026 | $64.1M | 624.4K | — | — |
| Q4 2025 | $127.7M | 1.02M | — | — |
| Q4 2025 | $127.7M | 1.02M | — | — |
| Q3 2025 | $157M | 1.17M | — | — |
Other funds holding ABT
$22.4B
$21.5B
$19.8B
$10.7B
$10.5B
$10.3B